25069
Dabigatran was granted marketing authorisation by the European Medicines Agency for a sequential dosing regimen ( DBG sequential ) , in which patients under 80 years are treated with dabigatran 150 mg twice daily ( DBG150 ) and patients 80 years and over are given dabigatran 110 mg twice daily ( DBG110 ) .
 Chemical: Dabigatran; Chemical: dabigatran; Chemical: dabigatran
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: Dabigatran; Chemical: dabigatran; Chemical: dabigatran